MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 50 filers reported holding MEI PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 1,064,995 | $244 | 1.26% |
| Anson Funds Management LP | 13,250,582 | $3,033,058 | 0.25% |
| TANG CAPITAL MANAGEMENT LLC | 5,163,456 | $1,181,915 | 0.18% |
| Mesirow Financial Investment Management, Inc. | 51,579 | $11,806 | 0.05% |
| CARLSON CAPITAL L P | 2,100,000 | $480,690 | 0.04% |
| Boxer Capital, LLC | 2,913,091 | $667 | 0.03% |
| Investmark Advisory Group LLC | 136,000 | $31,130 | 0.02% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 72,000 | $16 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,088 | 0.01% |
| BROOKS, MOORE & ASSOCIATES, INC. | 23,685 | $5 | 0.00% |
| Laurion Capital Management LP | 2,576,900 | $589,852 | 0.00% |
| Annandale Capital, LLC | 49,856 | $11 | 0.00% |
| PFG Investments, LLC | 33,500 | $7,668 | 0.00% |
| HighMark Wealth Management LLC | 10,600 | $2,426 | 0.00% |
| Renaissance Technologies | 2,804,357 | $642 | 0.00% |
| Virtu Financial LLC | 30,717 | $7 | 0.00% |
| Newbridge Financial Services Group, Inc. | 11,000 | $2,518 | 0.00% |
| Citadel Advisors | 43,300 | $9,911 | 0.00% |
| Citadel Advisors | 5,100 | $1,167 | 0.00% |
| Citadel Advisors | 518 | $119 | 0.00% |
External links
This page lists MEI PHARMA INC's shareholders in Q1 2023. To view MEI PHARMA INC's shareholder history, click here.